The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.

Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

As clinical research evolves at an unprecedented pace, it’s important that physicians understand how emerging trends may ...

By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...

The new approach brings research directly to participants using decentralised and patient-centric digital engagement tools.

Explore the unique mechanisms of bispecific antibodies and their rapid availability compared to CAR T-cell therapies in cancer treatment.

In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the ...

Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...

SHANGHAI, May 23, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at ...

FDA proposes framework clinical trial designs to guide Bayesian methods, improving efficiency in drug development for rare and pediatric conditions.

• In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer (“mCRPC”),the six-month radiographic ...